-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jonathan Toft, PharmD, MBA

Jonathan Toft, PharmD, MBA

Jonathan Toft, PharmD, MBA, is vice president of market access strategy at Lumanity.

Articles by Jonathan Toft, PharmD, MBA

Hiva Pourarsalan, Jonathan Toft, and Lisa Cashman

What Maximum Fair Prices Mean for Formulary Decision-Making

ByBrooke McCormick,Hiva Pourarsalan, PharmD,Jonathan Toft, PharmD, MBA,Lisa Cashman, PharmD

November 3rd 2026

Maximum Fair Prices are reshaping Part D formularies, with plans favoring lower net-cost options, panelists said at AMCP Nexus 2026.

Latest Updated Articles

Trending on AJMC

First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy

Unanswered Questions in First- and Second-Line mCRC Care

Planning for Third-Line Therapy and Treatment Rechallenge in mCRC

Multidisciplinary Care for Vitiligo: Beyond Dermatology

Precision Drugs Meet Payer Realities